This report highlights how pharmaceutical and medical device companies are creating shared value in global health by enhancing their corporate competitiveness while simultaneously addressing the global burden of disease; often working in partnership with governments, funders, and nonprofit organizations.
![](https://www.sharedvalue.org/wp-content/uploads/2019/11/RD_Denmark-1-760x506.jpg)